FDA.reportPublic FDA data

NDC11 62032010536

This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.

Possible FDA NDC forms#

Package NDC, Product root table
Package NDCProduct root
62032-0105-3662032-0105
62032-105-3662032-105

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 ยท 5 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Obagi-C C-Rx System Normal-Dry Skin InterventionHYDROQUINONE, HOMOSALATE, OCTISALATE, ZINC OXIDEObagi Cosmeceuticals LLCca931d1c-4df4-47ce-8d5c-cd8c3e38c02b2026-01-26WarningsExact identifier
ndc (package): 62032-105-36
ndc11 (package): 62032010536
Obagi-C C-Rx system Normal-oily skin InterventionHYDROQUINONE, TITANIUM DIOXIDE, ZINC OXIDEObagi Cosmeceuticals LLCa9ceacb3-d6e4-4316-a4e9-f15e574cdda02025-11-13WarningsExact identifier
ndc (package): 62032-105-36
ndc11 (package): 62032010536
Obagi-C C-Rx System Normal-Dry Skin InterventionHYDROQUINONE, TITANIUM DIOXIDE, ZINC OXIDEObagi Cosmeceuticals LLCe9d8488f-b902-45f4-a6d6-c6eb393c8f082025-11-13WarningsExact identifier
ndc (package): 62032-105-36
ndc11 (package): 62032010536
Obagi-C C-Rx System Normal-Oily Skin InterventionHYDROQUINONE, HOMOSALATE, OCTISALATE, ZINC OXIDEObagi Cosmeceuticals LLCe19b824f-4438-48c8-af4c-29be197f9cdc2025-10-21WarningsExact identifier
ndc (package): 62032-105-36
ndc11 (package): 62032010536
Obagi-C Rx system C-Therapy Night Skin Lightening with Vitamins C and EHYDROQUINONEObagi Cosmeceuticals LLC81e2e734-01fe-4568-903a-92993bf408872020-06-01Warnings, Adverse reactionsExact identifier
ndc (package): 62032-105-36
ndc (product): 62032-105
ndc11 (package): 62032010536

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.